XOMA Royalty (XOMA) Receivables (2010 - 2026)
XOMA Royalty (XOMA) reported Receivables of $4.6 million for Q1 2026, down 17.12% on a YoY basis from $5.5 million in Q1 2025, and up 1570.91% sequentially from $275000.0 in Q3 2025.
XOMA Royalty (XOMA) Receivables (2010 - 2026) Analysis & Trends
XOMA Royalty (XOMA) has 17 years of Receivables data on file, last reported at $4.6 million in Q1 2026.
- For the quarter ending Q1 2026, Receivables fell 17.12% year-over-year to $4.6 million; the trailing twelve-month figure through Mar 2026 stood at $4.6 million (down 17.12% YoY), and the FY2025 full-year result was $4.9 million, up 166.23% from the prior year.
- Receivables advanced to $4.6 million in Q1 2026, from $275000.0 in the prior quarter.
- In the past five years, Receivables ranged from a high of $14.8 million in Q2 2024 to a low of $6000.0 in Q1 2023.
- A 5-year average of $4.6 million and a median of $2.5 million in 2022 frame the typical range for Receivables.
- Across the five-year window, Receivables jumped 49950.0% in 2024 and tumbled 98.0% in 2025, its largest moves.
- Tracing XOMA's Receivables over 5 years: stood at $2.4 million in 2022, then surged by 491.67% to $14.2 million in 2023, then dropped by 3.2% to $13.7 million in 2024, then sank by 98.0% to $275000.0 in 2025, then jumped by 1570.91% to $4.6 million in 2026.
- Business Quant data shows XOMA's Receivables at $4.6 million in Q1 2026, $275000.0 in Q3 2025, and $1.8 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 4.97 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 938.02 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 1.13 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 2.00 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 5.73 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.93 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | XOMA Royalty | 478.42 Mn | 412.34 Mn | - | 4.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.60 Mn |
| Sep 17, 2025 | 275,000.00 |
| Jun 30, 2025 | 1.82 Mn |
| Mar 31, 2025 | 5.54 Mn |
| Sep 30, 2024 | 13.75 Mn |
| Jun 30, 2024 | 14.78 Mn |
| Mar 31, 2024 | 3.00 Mn |
| Dec 31, 2023 | 14.20 Mn |
| Sep 30, 2023 | 43,000.00 |
| Jun 30, 2023 | 5.90 Mn |
| Mar 31, 2023 | 6,000.00 |
| Dec 31, 2022 | 2.40 Mn |
| Sep 30, 2022 | 16,000.00 |
| Jun 30, 2022 | 2.51 Mn |
| Mar 31, 2022 | 25,000.00 |
| Sep 30, 2021 | 518,000.00 |
| Jun 30, 2021 | 12,000.00 |
| Mar 31, 2021 | 80,000.00 |
| Sep 30, 2020 | 222,000.00 |
| Jun 30, 2020 | 411,000.00 |